Medicare Part B Drug Average Sales Price Reporting by Manufacturers – Blending National Drug Codes
CMS is reminding manufacturers that ASP data must be reported for individual National Drug Codes (NDCs). As stated on page 45 of “ASP Data Collection (Addendum A) User’s Guide – Revised 2012” in the Downloads section at https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Part-B-Drugs/McrPartBDrugAvgSalesPrice/index.html, “most ASP reporting is done at the NDC level where the ASP corresponds to the amount of drug represented by that NDC.... For these drugs and biologicals, manufacturers will still submit ASP sales data for an NDC, but will do so on an ASP unit level specified in this list.” Manufacturers should not blend
MLN Matters® Number: SE1623 Related Change Request Number: N/APage 2 of 2 the manufacturer’s ASP or the number of ASP Units sold for a single NDC with other NDCs.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: September 09, 2016
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.